BioSyent Inc. (OTCMKTS:BIOYF) Short Interest Down 83.3% in April

BioSyent Inc. (OTCMKTS:BIOYF) was the recipient of a significant decrease in short interest during the month of April. As of April 15th, there was short interest totalling 500 shares, a decrease of 83.3% from the March 31st total of 3,000 shares. Based on an average daily trading volume, of 4,700 shares, the short-interest ratio is currently 0.1 days.

BioSyent Stock Performance

BIOYF remained flat at $6.28 during trading on Friday. The firm’s fifty day simple moving average is $6.34 and its two-hundred day simple moving average is $6.28. BioSyent has a fifty-two week low of $5.26 and a fifty-two week high of $6.97.

BioSyent Increases Dividend

The company also recently announced a dividend, which was paid on Friday, March 15th. Stockholders of record on Thursday, February 29th were paid a $0.0332 dividend. This is a positive change from BioSyent’s previous dividend of $0.03. The ex-dividend date of this dividend was Wednesday, February 28th. This represents a dividend yield of 2.08%.

BioSyent Company Profile

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.